Shares of Eli Lilly and Novo Nordisk slipped after UnitedHealth said it had concerns about the Medicare payment model that ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

GLP-1 medications are transforming obesity treatment, but real-world results consistently fall short of clinical trial outcomes, which sits at around 9% at 12 months, well below the 15% reported in ...

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 pills for weight loss may mark the most significant shift in the market yet. (Leila Register / NBC News; Getty Images) “The ...

Insurance coverage for GLP-1 medications like Ozempic and Wegovy varies widely depending on the condition and your plan.

Why do Ozempic and Zepbound work differently for everyone? A new study identifies genetic variants linked to GLP-1 weight loss and side effects.

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

“The GLP-1 landscape is expected to broaden significantly,” said Dr. Christopher McGowan, a gastroenterologist who runs a weight loss clinic in Cary, North Carolina. “For the first time, medical ...